Dr. Mohammed Al-Damluji, MD, MPH

Dr. Al-Damluji practices at Hartford Healthcare Medical Group Specialists in Middletown, Connecticut.

Dr. Al-Damluji's NPI, 1114312766, was assigned on March 31, 2015. Dr. Al-Damluji holds Connecticut license 65337.

Dr. Al-Damluji's primary practice is Hartford Healthcare Medical Group Specialists, at 420 Saybrook Rd, Middletown, CT 06457 in Lower Ct River Vly County. The practice phone is (860) 246-2071.

Dr. Al-Damluji's primary practice is Hartford Healthcare Medical Group Specialists in Middletown, Connecticut. Dr. Al-Damluji is also affiliated with Middlesex Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Al-Damluji to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Damluji practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Al-Damluji's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Al-Damluji is licensed in Connecticut.

CMS data shows 1,976 Medicare services from Dr. Al-Damluji across 18 procedure codes in 2024, for 1,132 Medicare patients. Medicare paid $102,651 for them.

CMS counts 1,132 Medicare patients who saw Dr. Al-Damluji in 2024. The largest group is 75 to 84, with 425 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Damluji's median patient age at 67, with 50% women.

In 2024, Dr. Al-Damluji wrote 1,349 Medicare Part D claims for 319 patients. 81% of them were for generic drugs. CMS names the drug for 1,202 of them, across 24 drugs with 11 or more claims each, at $263,990 in total drug cost. In 2023, CMS named 649 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Al-Damluji for performance year 2024, reported as part of a group. Dr. Al-Damluji accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al-Damluji as offering telehealth. CMS counts 11 procedures of coronary angioplasty and stenting by Dr. Al-Damluji, more than 30% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 15 general payments to Dr. Al-Damluji from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 78% of the total. Abbott Laboratories paid the most, $196.